BICYCLIC AND TRICYCLIC PYRIMIDINE TYROSINE KINASE INHIBITORS WITH ANTITUBULIN ACTIVITY AND METHODS OF TREATING A PATIENT
申请人:Duquesne University of The Holy Spirit
公开号:EP2670244A2
公开(公告)日:2013-12-11
[EN] BICYCLIC AND TRICYCLIC PYRIMIDINE TYROSINE KINASE INHIBITORS WITH ANTITUBULIN ACTIVITY AND METHODS OF TREATING A PATIENT<br/>[FR] INHIBITEURS PYRIMIDINES BICYCLIQUES ET TRICYCLIQUES DE TYROSINE KINASE AYANT UNE ACTIVITÉ ANTITUBULINE, ET MÉTHODES DE TRAITEMENT D'UN PATIENT
申请人:UNIV HOLY GHOST DUQUESNE
公开号:WO2012106522A2
公开(公告)日:2012-08-09
Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity are provided in the present invention. The compositions of the present invention possess dual activity in a single agent of potent vascular endothelial growth factor receptor inhibitory activity as well as antitubulin activity. Water soluble salts of these compositions are also described. Methods of treating a patient having cancer, macular degeneration, and arthritis with the compositions and salts thereof of the present invention are disclosed.